drugset / Trial / NCT06197308
Evaluation of an Oral Microbiota-based Therapeutic as a Treatment Option for PSC
NaSingle-groupOpen-labelTreatment
Summary
This pilot clinical trial will evaluate the initial safety and feasibility of microbiota transplant therapy (MTT) inpatients with primary sclerosing cholangitis (PSC). This trial will inform development of future trials in treatment of PSC.
Timeline
- Start
- 2024-03-01
- Primary completion
- 2027-03-31
- Completion
- 2027-09-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Amoxicillin | Other / unclassified | 1000 mg | Oral |
| Background | Vancomycin | Other / unclassified | 500 mg | Oral |